QS Investors’s Impax Laboratories, Inc. IPXL Stock Holding History

QS Investors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-272	Closed	-$5K	–	2003
2017 Q4	$5K	Hold	272	–	–	﹤0.01%	1612
2017 Q3	$6K	Hold	272	–	–	﹤0.01%	1627
2017 Q2	$4K	Sell	272 -118,055	-100%	-$1.74M	﹤0.01%	1648
2017 Q1	$1.5M	Hold	118,327	–	–	0.01%	679
2016 Q4	$1.57M	Sell	118,327 -53,910	-31%	-$922K	0.01%	672
2016 Q3	$4.08M	Buy	172,237 +2,180	+1%	+$58.6K	0.03%	441
2016 Q2	$4.9M	Hold	170,057	–	–	0.04%	394
2016 Q1	$5.45M	Sell	170,057 -7,416	-4%	-$261K	0.05%	355
2015 Q4	$7.59M	Sell	177,473 -5,783	-3%	-$231K	0.07%	250
2015 Q3	$6.45M	Sell	183,256 -1,009	-0.5%	-$45.5K	0.07%	271
2015 Q2	$8.46M	Hold	184,265	–	–	0.1%	240
2015 Q1	$8.64M	Sell	184,265 -16,975	-8%	-$675K	0.1%	239
2014 Q4	$6.38M	Buy	+201,240	New	+$5.89M	0.07%	297

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QS Investors's IPXL Position: Q1 2018 in Review

QS Investors sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 272 shares — an estimated $5K sold.

QS Investors first reported a position in IPXL in Q4 2014 and held it in 13 quarters. The position peaked at $8.64M in Q1 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

QS Investors reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
QS Investors sold 272 Impax Laboratories, Inc. shares in Q1 2018, an estimated $5K.
QS Investors first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 13 quarters.
QS Investors's Impax Laboratories, Inc. position peaked at $8.64M in Q1 2015.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on QS Investors's 13F filing for Q1 2018, filed 15 May 2018.